SEC Form 4 · accession 0001209191-19-004546
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Todd Christopher Longsworth
Officer — General Counsel
Period of report
Jan 16, 2019
Accepted (ET)
Jan 18, 2019 · 4:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jan 16, 2019 | M | 15,000 | $7.15 | A | 36,305 | D | |
| Ordinary SharesF2 | Jan 16, 2019 | S | 15,000 | $45.15 | D | 21,305 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to Buy Ordinary SharesF3 | $7.15 | Jan 16, 2019 | M | 15,000 | D | — | Feb 21, 2027 | Ordinary Shares | 15,000 | 181,547 | D |
Explanation of responses
- F1These shares were acquired pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth.
- F2These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth.
- F3Fully vested and exercisable as of the date hereof.